# BPA Call Order for Clinical Chemistry & Immunoassay Reagents

Canonical: https://abierto.us/opportunities/w81k0224f0060

- Solicitation number: W81K0224F0060
- Notice type: Presolicitation
- Status: Awarded to Abbott Laboratories Inc.
- Department: Department of the Army
- Agency: Department of the Army
- Contracting office: W40M Mrco Pacific (W81K02)
- NAICS: 325413 In-Vitro Diagnostic Substance Manufacturing
- Product or service code: 6550 In Vitro Diagnostic Substances, Reagents, Test Kits and Sets
- Place of performance: Tripler Army Medical Center, Hawaii
- First posted: April 26, 2024
- Last posted: April 26, 2024
- SAM.gov: https://sam.gov/workspace/contract/opp/7680a2e239114913b565598d879fcc48/view

## Description

The Medical Readiness Contracting Office – Pacific intends to issue a bulk-funded BPA call to Abbott Laboratories Inc. for Clinical Chemistry and Immunoassay reagents for May 2024 for Tripler Army Medical Center, Hawaii.

The statutory authority permitting this award without providing full and open competition is FAR 13.106-1(b)(1)(i), which authorizes the Government to award contracts when the circumstances of the contract action deem only one reasonably available and no other suppliers or services will satisfy agency requirements. This announcement fulfills the synopsis requirement under FAR 5.201 and 5.203. This Notice of Intent is not a request for competitive quotes.

Information received in response to this notice will be considered solely for the purpose of determining whether a competitive procurement is in the best interest of the Government.

**Disclaimer and Important Notes:** This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to supply the required products. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. No proprietary, classified, confidential, or sensitive information should be included in your response.

## Award on USAspending

- Recipient: Abbott Laboratories Inc. (UEI NH3LDK8CFAK7)
- Contract: W81K0224F0060 under W81K0224A0005, bpa call
- Obligated: $165,000.00
- Competition: Not Competed Under SAP, 1 offers received
- Link: solicitation number W81K0224F0060 was reused as the contract number; same awarding office W81K02 (high confidence)
- Record: https://www.usaspending.gov/award/CONT_AWD_W81K0224F0060_9700_W81K0224A0005_9700/


## Publications

- April 26, 2024: Presolicitation, due May 3, 2024 at 4:00 PM EDT. Notice 7680a2e239114913b565598d879fcc48. https://sam.gov/workspace/contract/opp/7680a2e239114913b565598d879fcc48/view

## Points of contact

- Megumi Kuwada, megumi.kuwada.civ@health.mil, 8084339489

---
Source: SAM.gov Contract Opportunities bulk extract and USAspending.gov award data. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/w81k0224f0060.